Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alx Oncology Holdings (ALXO) Non Operating Income (2020 - 2026)

Alx Oncology Holdings' Non Operating Income history spans 4 years, with the latest figure at -$29000.0 for Q4 2023.

  • On a quarterly basis, Non Operating Income fell 1350.0% to -$29000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $389000.0, a 1868.18% increase, with the full-year FY2025 number at -$36000.0, down 123.53% from a year prior.
  • Non Operating Income hit -$29000.0 in Q4 2023 for Alx Oncology Holdings, down from -$1000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for ALXO hit a ceiling of $7.8 million in Q4 2020 and a floor of -$305000.0 in Q2 2020.
  • Historically, Non Operating Income has averaged $483750.0 across 4 years, with a median of -$2000.0 in 2021.
  • The widest YoY moves for Non Operating Income: up 6580.0% in 2023, down 1350.0% in 2023.
  • Tracing ALXO's Non Operating Income over 4 years: stood at $7.8 million in 2020, then crashed by 99.94% to $5000.0 in 2021, then crashed by 140.0% to -$2000.0 in 2022, then crashed by 1350.0% to -$29000.0 in 2023.
  • Business Quant data shows Non Operating Income for ALXO at -$29000.0 in Q4 2023, -$1000.0 in Q3 2023, and $324000.0 in Q2 2023.